Barbara N. Gross

Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome.

R. Wäsch, G. Ihorst, M. Engelhardt, 2013, Clinical lymphoma, myeloma & leukemia.

Vorinostat (V) In Combination With Bortezomib (B), Doxorubicin (D) and Dexamethasone (D) (VBDD) In Patients With Refractory Or Relapsed Multiple Myeloma: An Interim Phase I/II Analysis

M. Jung, M. Engelhardt, A. May, 2013 .

Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany

W. Kern, K. With, M. Steib-Bauert, 2015, Infection.

Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia

M. Kiehl, M. Engelhardt, G. Egerer, 2015, Mycoses.

Posaconazole Therapeutic Drug Monitoring in the Real‐life Setting: A Single‐Center Experience and Review of the Literature

M. Jung, R. Wäsch, G. Ihorst, 2013, Pharmacotherapy.

Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia

M. Kiehl, M. Engelhardt, G. Egerer, 2015, Mycoses.